New therapeutic approaches to diabetic gastroparesis;Neue behandlungsmöglichkeit bei diabetischer gastroparese

Medizinische Klinik

Volumn 103, Issue 7, 2008, Pages 514-518

  Hummel, Michael ^a   Geigenberger, Gudrun ^b   Brand, Johann ^a   Ziegler, Anette G ^a   Füchtenbusch, Martin ^a  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^b Klinikum Schwabing   (Germany)

Author keywords

Autonomic neuropathy; Botulinum toxin; Diabetes; Gastroparesis

Indexed keywords

BOTULINUM TOXIN;

ADULT; ARTICLE; BLOATING; CASE REPORT; CLINICAL FEATURE; DIABETIC GASTROPARESIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; JEJUNOSTOMY; MALE; NAUSEA; PHYSICAL EXAMINATION; SATIETY; SCORING SYSTEM; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS; STOMACH SCINTISCANNING; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; WELLBEING;

BOTULINUM TOXIN TYPE A; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; ENTERAL NUTRITION; FOLLOW-UP STUDIES; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; PYLORIC ANTRUM; RETREATMENT; YOUNG ADULT;

EID: 52249103284     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-008-1075-2     Document Type: Article

References (25)

1. Maleki D, Locke GR III, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000;160:2808-16.
2. Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001;161:1989-96.
3. Horowitz M, Maddox AT, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991;18:229-34.
4. Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001;24:1264-9.
5. Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med 2007;356:820-9.
6. Horowitz M, Harding PE, Maddox A, et al. Gastric andesophageal emptying in insulin-dependent diabetes mellitus. J Gastroenterol Hepatol 1986;1:97-113.
7. Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol 2006;101:1129-39.
8. Zarate N, Mearin F, Wang XY, et al. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut 2003;52:966-70.
9. Abell TL, Bernstein VK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006;18:263-83.
10. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004;127:1592-622.
11. Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 diabetes mellitus. Diabetologia 1990;33:675-80.
12. O'Donovan D, Feinle-Bisset C, Jones K, et al. Idiopathic and diabetic gastroparesis. Curr Treat Options Gastroenterol 2003;6:299-309.
13. Ramsbottom N, Hunt JN. Studies of the effect of metoclopramide and apomorphine on gastric emptying and secretion in man. Gut 1970;11:989-93.
14. Silvers D, Kipnes M, Broadstone V, et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther 1998;20:438-53.
15. Patterson D, Abell T, Rothstein R, et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999;94:1230-4.
16. Rayner CK, Horowitz M. New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol 2005;2:454-62.
17. Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003;98:2122-9.
18. Abell T, McCallum R, Hocking M, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003;125:421-8.
19. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986;90:1919-25.
20. James AN, Ryan JP, Parkman HP. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol 2003;285:291-7.
21. Lacy BE, Crowell MD, Schettler-Duncan A, et al. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004;27:2341-7.
22. Ezzeddine D, Jit R, Katz N, et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002;55:920-3.
23. Haans JJL, Masclee AAM. Review article: The diagnosis and management of gastroparesis. Aliment Pharmacol Ther 2007;26:Suppl 2:37-46.
24. Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: A randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007;26:1251-8.
25. Friedenberg FK, Palit A, Parkman HP, et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008;103:416-23.